The new go-private price for Converge Technology Solutions is $6.00 and Ventum Capital Markets analyst Rob Goff thinks that ...

He’s has a “Buy” rating on the stock, but TD Cowen analyst Vince Valentini thinks 2025 could be a rocky road for Rogers ...

What’s the latest on Donald Trump’s tariffs? You might want to check your watch, not your calendar say economists at RBC.

The biggest Liberation Day winner”. That’s where Citi analyst James Hardiman thinks BRP stands in the North American travel ...

Its fourth quarter results are in the books and Haywood analyst Neal Gilmer has maintained his “Buy” rating on Rubicon ...

Fund manager Greg Newman of Newman Group ScotiaMcLeod says he is “going out on a limb” by making Telus one of his top picks.

Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained his “Buy” rating on Organigram.

Following the company’s fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technologies ...

Delayed financials from WELL Health mean an opportunity for investors, says Ventum Capital Markets analyst Rob Goff.

TD Cowen analyst Vince Valentini says he is feeling more bullish about Quebecor, and has raised his price target on it.

Following the company’s fourth quarter results, RBC analyst Paul Treiber has cut his price target on BlackBerry ...

HEALWELL AI has made an acquisition that will present the company with immediate upsell opportunities., says Raymond James ...